medical guideline

首页 肿瘤学指南 卵巢肿瘤 详情

Epithelial Ovarian Cancer and Fertility Preservation: Article Drafted from the French Guidelines in Oncology Entitled “Initial Management of Patients with Epithelial Ovarian Cancer” Developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY Under the Aegis of CNG

原文:2019年 发布于 Gynecologie Obstetrique Fertilite et Senologie 47卷 第2期 180 - 186 浏览量:290 原文链接
指南简介

Objectives: To study the methods and strategies of fertility preservation in young women with stage I epithelial ovarian cancer (EOC), in order to provide recommendations for clinical practice. Methods: The PubMed database was searched for english and french language articles, between 2005 and 2001, according to predefined search equations. Results: Young patients with stage IA EOC willing to conceive should be informed that conservative treatment (contralateral ovary and salpinx, uterus) is possible (Grade C), associated with a 6 % to 13 % recurrence risk (Grade C) on the remaining ovary. This conservative surgical treatment includes adnexectomy, peritoneal and lymph node staging for all subtypes, and additional endometrial curettage for endometriosis and mucinous subtypes (Grade C). In case of positive staging conservative treatment is not possible. In case of mucinous EOC with an infiltrative pattern, lymph node staging is not necessary. Multidisciplinary analysis (including oncologists and reproductive medicine specialists) of the risk-benefit balance for a conservative surgery is recommended and must rely on a complete final pathology report (Grade C). No recommendation on bilateral adnexectomy and uterine conservation to allow pregnancy using egg donation can be provided in case of low-grade stage IA EOC, in the absence of data. Bilateral adnexectomy and uterine conservation to allow pregnancy using egg donation can be offered in case of serous, mucinous or endometrioid high-grade FIGO stage IA or low-grade FIGO stage IC1 or IC2 EOC (Grade C). Preservation of the uterus and contralateral ovary and Fallopian tube can be discussed with a specialized rare ovarian tumors multidiciplinary staff in case of clear cell stage I EOC.